6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19317342 | SINGLE BASE SUBSTITUTION PROTEIN, AND COMPOSITION COMPRISING SAME | REGA, KYLE THOMAS | 1636 | Non-Final OA | Sep 03, 2025 |
| 18467967 | Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells | HIBBERT, CATHERINE S | 1658 | Non-Final OA | Sep 15, 2023 |
| 18313946 | COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF | HIBBERT, CATHERINE S | 1658 | Non-Final OA | May 08, 2023 |
| 17792203 | CELLS HAVING HIGH ADAPTABILITY UNDER HYPOXIC CONDITIONS, AND USE THEREOF | MATALKAH, FATIMAH KHALAF | 1638 | Non-Final OA | Jul 12, 2022 |
| 17262342 | GENE EDITING OF ANTICOAGULANTS | MEYERING, SHABANA SHABBEER | 1635 | Final Rejection | Jan 22, 2021 |
| 17004355 | COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF | HIBBERT, CATHERINE S | 1658 | Final Rejection | Aug 27, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial